Sodium Hydroxide → 5-[(2-Fluorophenyl)amino]-N-[4-(4-isopropylpiperazin-1-yl)phenyl]-1,3,4-oxadiazole-2-carboxamide

HRID 1713729Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1713729
[F:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[NH:8][C:9]1[O:13][C:12]([C:14]([O:16]CC)=O)=[N:11][N:10]=1.[OH-].[Na+].[CH:21]([N:24]1[CH2:29][CH2:28][N:27]([C:30]2[CH:35]=[CH:34][C:33]([NH2:36])=[CH:32][CH:31]=2)[CH2:26][CH2:25]1)([CH3:23])[CH3:22].C1C=CC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C>O.CN(C=O)C>[F:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[NH:8][C:9]1[O:13][C:12]([C:14]([NH:36][C:33]2[CH:32]=[CH:31][C:30]([N:27]3[CH2:26][CH2:25][N:24]([CH:21]([CH3:23])[CH3:22])[CH2:29][CH2:28]3)=[CH:35][CH:34]=2)=[O:16])=[N:11][N:10]=1

Komponenten

8

Versuchsvorschrift

Ethyl 5-[(2-fluorophenyl)amino]-1,3,4-oxadiazole-2-carboxylate (Intermediate 40, 94 mg, 0.37 mmol) was stirred in water (1 mL). Sodium hydroxide (37 mg, 0.925 mmol) was dissolved in water (0.5 mL) and added to the reaction mixture. After stirring for 1 h the reaction was concentrated in vacuo to give a yellow solid which was dissolved in DMF (1 mL). [4-(4-Isopropylpiperazin-1-yl)phenyl]amine (WO02/057261) (89 mg, 0.41 mmol) dissolved in DMF (1 mL), HOBt (100 mg, 0.74 mmol), and EDAC (142 mg, 0.74 mmol) were added. The reaction was allowed to stir for 3 h then water (20 mL) was added and the reaction mixture thoroughly shaken to give a precipitate. After filtration and drying under in vacuo the title compound was obtained as a cream solid (69 mg, 44%):

Aufarbeitung

  1. additionadded to the reaction mixture
  2. concentrationwas concentrated in vacuo
  3. customto give a yellow solid which
  4. stirringto stir for 3 h
  5. stirringthe reaction mixture thoroughly shaken
  6. customto give a precipitate
  7. filtrationAfter filtration
  8. dry with materialdrying under in vacuo the title compound

Quellen und Nachweise

ORD-Eintrag
ord-a667fa37d5734eeca1814b1d90814af9
Quelldatensatz
uspto-grants-2010_09
Patentnummer
US07795283B2

Notizen zur Reaktion

Wird geladen…